Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates

Molecular Medicine

Volumn 5, Issue 5, 1999, Pages 287-300

  McCluskie, Michael J ^a,b   Brazolot Millan, Cynthia L ^a   Gramzinski, Robert A ^c   Robinson, Harriet L ^d   Santoro, Joseph C ^d   Fuller, James T ^e   Widera, Georg ^e   Haynes, Joel R ^e   Purcell, Robert H ^f   Davis, Heather L ^a,b,g  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e Powderject Vaccines   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g Faculty of Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HEPATITIS B; IMMUNE RESPONSE; INFECTION PREVENTION; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; MONKEY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; SPECIES DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0032813403     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402065     Document Type: Article

References (84)

1. 1. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. (1997) DNA vaccines. Annu. Rev. Immunol. 15: 617-648.
2. 2. Davis HL, McCluskie MJ. (1999) DNA vaccines for viral diseases. Microbes and Infection 1: 7-23.
3. 3. MacGregor RR, Boyer JD, Ugen KE, et al. (1998) First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178: 92-100.
4. 4. Calarota S, Bratt G, Nordlund S, et al. (1998) Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351: 1320-1325.
5. 5. Wang R, Doolan DL, Le TP, et al. (1998) Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282: 476-480.
6. 6. Ugen KE, Nyland SB, Boyer JD, et al. (1998) DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine 16: 1818-1821.
7. 7. Davis HL, Brazolot Millan CL, Watkins SC. (1997) Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 4: 181-188.
8. 8. Casares S, Inaba K, Brumeanu TD, Steinman RM, Bona CA. (1997) Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186: 1481-1486.
9. 9. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2: 1122-1128.
10. 10. Krieg AM, Yi AK, Matson S, et al. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
11. 11. Sato Y, Roman M, Tighe H, et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354.
12. 12. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 90: 11478-11482.
13. 13. Feltquate DM, Heaney S, Webster RG, Robinson HL. (1997) Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Jmmunol. 158: 2278-2284.
14. 14. Pertmer TM, Roberts TR, Haynes JR. (1996) Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70: 6119-6125.
15. 15. Davis HL, Whalen RG, Demeneix BA. (1993) Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4: 151-159.
16. 16. Davis HL, Michel ML, Whalen RG. (1993) DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2: 1847-1851.
17. 17. Davis HL, McCluskie MJ, Gerin JL, Purcell RH. (1996) DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc. Natl. Acad. Sci. U.S.A. 93: 7213-7218.
18. 18. Davis HL, Schleef M, Moritz P, Mancini M, Schorr J, Whalen RG. (1996) Comparison of plasmid DNA preparation methods for direct gene transfer and genetic immunization. Biotechniques 21: 92-94, 96-99.
19. 19. Davis HL, Mancini M, Michel ML, Whalen RG. (1996) DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14: 910-915.
20. 20. Cardoso AI, Sixt N, Vallier A, Fayolle J, Buckland R, Wild TF. (1998) Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunizcd antigen. J. Virol. 72: 2516-2518.
21. 21. Tang D, De Vit M, Johnston SA. (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152-154.
22. 22. Raz E, Carson DA, Parker SE, et al. (1994) Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. U.S.A. 91: 9519-9523.
23. 23. Gramzinski RA, Brazolot Millan CL, Obaldia N, Hoffman SL, Davis HL. (1998) Immune response to a hepatitis B DNA vaccine in Aotus monkeys - a comparison of vaccine formulation, route, and method of administration. Mol. Med. 4: 109-118.
24. 24. Ishii N, Fukushima J, Kaneko T, et al. (1997) Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 13: 1421-1428.
25. 25. Yokoyama M, Zhang J, Whitton J. (1996) DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity. FEMS Immunol. Med. Microbiol. 14: 221-230.
26. 26. Liu Y, Mounkes LC, Liggitt HD, et al. (1997) Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery, Nat. Biotech. 15: 167-173.
27. 27. Kuklin N, Daheshia M, Karem K, Manickan E, Rouse BT. (1997) Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71: 3138-3145.
28. 28. Sasaki S, Hamajima K, Fukushima J, et al. (1998) Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine. Infect. Immun. 66: 823-826.
29. 29. Okada E, Sasaki S, Ishii N, et al. (1997) Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF) -expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159: 3638-3647.
30. 30. Chen SC, Jones DH, Fynan EF, et al. (1998) Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72: 5757-5761.
31. 31. Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH. (1997) Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 15: 814-817.
32. 32. Etchart NR, Buckland R, Liu MA, Wild TF, Kaiserlian D. (1997) Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78: 1577-1580.
33. 33. Hinkula J, Lundholm P, Wahren B. (1997) Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine 15: 874-878.
34. 34. Livingston JB, Lu S, Robinson H, Anderson DJ. (1998) Immunization of the female genital tract with a DNA-based vaccine. Infect. Immun. 66: 322-329.
35. 35. Macklin MD, McCabe D, McGregor MW, et. al, (1998) Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J. Virol. 72: 1491-1496.
36. 36. Keller ET, Burkholder JK, Shi F, et al. (1996) In vivo particle-mediated cytokine gene transfer into canine oral mucosa and epidermis. Cancer Gene Ther. 3: 186-191.
37. 37. Wang B, Dang K, Agadjanyan MG, et al. (1997) Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine 15: 821-825.
38. 38. Bagarazzi ML, Boyer JD, Javadian MA, et al. (1997) Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees. J. Med. Primatol. 26: 27-33.
39. 39. Daheshia M, Kuklin N, Manickan E, Chun S, Rouse BT. (1998) Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine 16: 1103-1110.
40. 40. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG. (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. U.S.A. 92: 5307-5311.
41. 41. Anonymous. (1997) Vectors for gene therapy. In: Dracopoli N, Haines JL, Korf BR, et al. (eds). Current Protocals in Human Genetics. John Wiley and Sons, New York, pp. 12.6.1-12.6.2.
42. 42. Davis HL, Michel M-L, Mancini M, Schleef M, Whalen RG. (1994) Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12: 1503-1509.
43. 43. Davis HL, Weeranta R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM. (1998) CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160: 870-876.
44. 44. Brazolot Millan CL, Weeratna R, Krieg AM, Siegrist CA, Davis HL. (1998) CpG DNA induces strong Th1 responses against hepatitis B surface antigen in neonatal mice. Proc. Natl. Acad. Sci. U.S.A. 95: 15553-15558.
45. 45. McCluskie MJ, Davis HL. (1998) CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161: 4463-4466.
46. 46. Gregoriadis G, Saffie R, de Souza JB. (1997) Liposome-mediated DNA vaccination. FEES Lett. 402: 107-110.
47. 47. Blessing T, Remy JS, Behr JP. (1998) Monomolecular collapse of plasmid DNA into stable viruslike particles. Proc. Natl. Acad. Sci. U.S.A. 95: 1427-1431.
48. 48. Haynes JR, McCabe DE, Swain WF, Widera G, Fuller JT. (1996) Particle-mediated nucleic acid immunization, J. Biotechnol. 44: 37-42.
49. 49. Krieg AM, Wu T, Weeratna R, et al. (1998) Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. U.S.A. 95: 12631-12636.
50. 50. Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH. (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158: 4591-4601.
51. 51. Geissler MA, Gesien A, Tokushige K, Wands JR. (1997) Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J, Immunol. 158: 1231-1237.
52. 52. Fuller DH, Corb MM, Barnett S, Steimer K, Haynes JR. (1997) Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 15: 924-926.
53. 53. Prayaga SK, Ford MJ, Haynes JR. (1997) Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. Vaccine 15: 1349-1352.
54. 54. Schneider J, Gilbert SC, Blanchard TJ, et al. (1998) Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4: 397-402.
55. 55. Richmond JFL, Lu S, Santoro JC, et al. (1998) Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 env antibody elicited by DNA priming and protein boosting. J. Virol. 72: 9092-9100.
56. 56. Robinson HL, Boyle CA, Feltquate DM, Morin MJ, Santoro JC, Webster RG. (1997) DNA immunization for influenza virus: studies using hemagglutinin-and nucleoprotein-expressing DNAs. J. Infect. Dis. 176: S50-S55.
57. 57. Robinson HL, Torres CA. (1997) DNA vaccines. Semin. Immunol. 9: 271-283.
58. 58. Wolff JA, Malone RW, Williams P, et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468.
59. 59. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. (1992) Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1: 363-369.
60. 60. Ulmer JB, Deck RR, Dewitt CM, et al. (1996) Expression of a viral protein in muscle cells in vivo induces protective cell-mediated immunity. Immunology 89: 59-67.
61. 61. Corr M, Lee DJ, Carson DA, Tighe H. (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184: 1555-1560.
62. 62. Doe B, Selby M, Barnett S, Baenziger J, Walker CM. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. U.S.A. 93: 8578-8583.
63. 63. Iwasaki A, Torres CA, Ohashi PS, Robinson HL, Barber BH. (1997) The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159: 11-14.
64. 64. Torres CA, Iwasaki A, Barber BH, Robinson HL, (1997) Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158: 4529-4532.
65. 65. Chattergoon MA, Robinson TM, Boyer JD, Weiner DB. (1998) Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/ antigen-presenting cells. J. Immunol. 160: 5707-5718.
66. 66. Mathiowitz E, Jacob JS, Jong YS, et al. (1997) Biologically erodable microspheres as potential oral drug delivery systems. Nature 386: 410-414.
67. 67. Barry MA, Johnston SA. (1997) Biological features of genetic immunization. Vaccine 15: 788-791.
68. 68. Cardoso AI, Blixenkrone-Moller M, Fayolle J, Liu M, Buckland R, Wild TF. (1996) Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology 225: 293-299.
69. 69. Boyle JS, Koniaras C, Lew AM. (1997) Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol 9: 1897-1906.
70. 70. Mor G, Klinman DM, Shapiro S, et al. (1995) Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J. Immunol. 155: 2039-2046.
71. 71. Fuller DH, Haynes JR. (1994) A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses 10: 1433-1441.
72. 72. Klinman DM, Yamshchikov G, Ishigatsubo Y. (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158: 3635-3639.
73. 73. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186: 1623-1631.
74. 74. Kim JJ, Ayyavoo V, Bagarazzi ML, et al. (1997) In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158: 816-826.
75. 75. Kim JJ, Trivedi NN, Nottingham LK, et al. (1998) Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28: 1089-1103.
76. 76. Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT. (1995) Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155: 259-265.
77. 77. Leclerc C, Deriaud E, Rojas M, Whalen RG. (1997) The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell Immunol. 179: 97-106.
78. 78. Fuller DH, Murphey-Corb M, Clements J, Barnett S, Haynes JR. (1996) Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J. Med. Primatol. 25: 236-241.
79. 79. Wang R, Doolan DL, Charoenvit Y, et al. (1998) Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect. Immun. 66: 4193-4202.
80. 80. Le Borgne S, Mancini M, Le Grand R, et al. (1998) In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 240: 304-315.
81. 81. Buyer JD, Wang B, Ugen KE, et al. (1996) In vivo protective anti-HIV immune responses in nonhuman primates through DNA immunization. J. Med. Primatol. 25: 242-250.
82. 82. Boyer JD, Ugen KE, Wang B, et al. (1997) Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3: 526-532.
83. 83. Prince AM, Whalen R, Brotman B. (1997) Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine 15: 916-919.
84. 84. Ugen KE, Boyer JD, Wang B, et al. (1997) Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine 15: 927-930.